PATENT CLAIM ANALYSIS

Application Number: 15862721
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-07
Patent Classification: ["514", "320000"]

Abstract:
Oral formulations of benzofuran compounds which modulate cannabinoid receptors are presented. Methods of using these formulations for treatment of cannabinoid receptor-mediated disease, including neuropathic pain and addition, are also described.

Claim (Index 9):
A method of treatment of a cannabinoid receptor-mediated disease comprising administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition according to  claim 1 .

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.25926
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12668867', '12668840', '13871146', '12582417', '14746562']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7584306682596896
- 35 USC 102 Novelty (BERT): 0.469840653807128
- Combined Prediction Score: 0.7295716668144334
- Mean Citation Score: 201.03364
- Max Citation Score: 209.21481
- Similarity Product: 181.8311798599756

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test